Dzamko N - Search Results

1

Lipid pathway dysfunction is prevalent in patients with Parkinson's disease.

Galper J, Dean NJ, Pickford R, Lewis SJG, Halliday GM, Kim WS, Dzamko N. Galper J, et al. Among authors: dzamko n. Brain. 2022 Oct 21;145(10):3472-3487. doi: 10.1093/brain/awac176. Brain. 2022. PMID: 35551349 Free PMC article.

2

An emerging role for LRRK2 in the immune system.

Dzamko N, Halliday GM. Dzamko N, et al. Biochem Soc Trans. 2012 Oct;40(5):1134-9. doi: 10.1042/BST20120119. Biochem Soc Trans. 2012. PMID: 22988878 Review.

3

Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients.

Dzamko N, Chua G, Ranola M, Rowe DB, Halliday GM. Dzamko N, et al. J Parkinsons Dis. 2013;3(2):145-52. doi: 10.3233/JPD-130174. J Parkinsons Dis. 2013. PMID: 23938344

4

DNA extraction from fresh-frozen and formalin-fixed, paraffin-embedded human brain tissue.

Wang JH, Gouda-Vossos A, Dzamko N, Halliday G, Huang Y. Wang JH, et al. Among authors: dzamko n. Neurosci Bull. 2013 Oct;29(5):649-54. doi: 10.1007/s12264-013-1379-y. Epub 2013 Aug 30. Neurosci Bull. 2013. PMID: 23996594 Free PMC article.

5

Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.

Dzamko N, Zhou J, Huang Y, Halliday GM. Dzamko N, et al. Front Mol Neurosci. 2014 Jun 24;7:57. doi: 10.3389/fnmol.2014.00057. eCollection 2014. Front Mol Neurosci. 2014. PMID: 25009465 Free PMC article. Review.

6

Inflammation is genetically implicated in Parkinson's disease.

Dzamko N, Geczy CL, Halliday GM. Dzamko N, et al. Neuroscience. 2015 Aug 27;302:89-102. doi: 10.1016/j.neuroscience.2014.10.028. Epub 2014 Oct 22. Neuroscience. 2015. PMID: 25450953 Review.

7

Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.

Dzamko N, Rowe DB, Halliday GM. Dzamko N, et al. Mov Disord. 2016 Jun;31(6):889-97. doi: 10.1002/mds.26529. Epub 2016 Feb 25. Mov Disord. 2016. PMID: 26917005

8

Inhibitor treatment of peripheral mononuclear cells from Parkinson's disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker.

Perera G, Ranola M, Rowe DB, Halliday GM, Dzamko N. Perera G, et al. Among authors: dzamko n. Sci Rep. 2016 Aug 9;6:31391. doi: 10.1038/srep31391. Sci Rep. 2016. PMID: 27503089 Free PMC article.

9

Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease.

Matrone C, Dzamko N, Madsen P, Nyegaard M, Pohlmann R, Søndergaard RV, Lassen LB, Andresen TL, Halliday GM, Jensen PH, Nielsen MS. Matrone C, et al. Among authors: dzamko n. PLoS One. 2016 Aug 10;11(8):e0160501. doi: 10.1371/journal.pone.0160501. eCollection 2016. PLoS One. 2016. PMID: 27509067 Free PMC article.

10

Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.

Dzamko N, Gysbers A, Perera G, Bahar A, Shankar A, Gao J, Fu Y, Halliday GM. Dzamko N, et al. Acta Neuropathol. 2017 Feb;133(2):303-319. doi: 10.1007/s00401-016-1648-8. Epub 2016 Nov 25. Acta Neuropathol. 2017. PMID: 27888296 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters